Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Aspirin/sumatriptan 325/12.5; VVD 101

Latest Information Update: 11 Apr 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vivid Pharma Inc
  • Class Antimigraines; Indoles; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Cyclooxygenase inhibitors; Serotonin 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Suspended Headache

Most Recent Events

  • 11 Apr 2017 Suspended - Phase-II for Headache (delayed alcohol induced) in USA (PO)
  • 01 Jan 2016 Vivid Pharma completes a phase II trial in Headache (delayed alcohol indced) in USA (NCT02176655)
  • 01 Jul 2014 Phase-II clinical trials in Headache (delayed alcohol induced) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top